Openbookopenbook
Openbook
CNBS
+3.46 · +14.41%
$27.45 · NYSE ARCA

Amplify Seymour Cannabis ETF (CNBS) ETF Analysis | Miscellaneous Sector

Amplify ETFs · USA
AUM:$73.7M
#– of – in Miscellaneous Sector ETFs

Educational tool only – Figures are based on historical data, holdings and expense metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Market Performance

Up 5.8% over the past year, showing positive momentum.

Cost Efficiency

Ongoing charge of 0.75% — moderate cost. Consider how fees compound over long holding periods.

What is CNBS?

Under normal market conditions, the fund seeks to achieve its investment objective by investing in the securities of U. companies engaged in cannabis and hemp-related activities selected by the fund"s investment adviser, Amplify Investments LL.

Performance Highlights

Returns (%)
Cost & Yield (%)

Investment Breakdown

Positive 1-Year Return
CNBS returned 5.8% over the past year. Historical returns only — past performance is not indicative of future results.
Moderate Cost
Expense ratio of 0.75%. Consider how fees compound over a long holding period.
Broadly Diversified
Top 10 holdings represent just 21.3% of the ETF — exposure spread across many positions.
ETF Information
AUM$73.7M
Expense Ratio0.75%
Dividend Yield0.00%
Holdings13
Inception DateJul 2019
Domicile–
Distribution–
Index–
ProviderAmplify ETFs
Beta0.27
CategoryMiscellaneous Sector
CurrencyUSD
Portfolio Impact

How would CNBS affect your portfolio?

Sign in to see exactly what adding this ETF changes — sector exposure, yield, diversification, volatility. Real numbers from your actual holdings.

Sign in
Example preview
6168
+7 points · better diversified

Chart Tools

My Portfolio

Sign in to overlay your portfolio on the chart.

Sign in
Compare Equity
Uses ISF.L (iShares FTSE 100 ETF)
Indicators

Performance Metrics

Historical returns

6M
+22.3%
1Y
-14.9%
3Y
-5.7%
5Y
-83.1%
OpenBook InsightIf you had invested £10,000 in CNBS 5 years ago, it would have fallen to £1,690 — a loss of £8,310.

Annual Returns

Calendar year performance

CNBS delivered positive returns in 2 of the last 5 calendar years.
YearCNBS
2026 YTD+0.3%
2025+8.9%
2024-28.4%
2023-17.2%
2022-64.8%
CAGR 4yr-30.9%
2/5 positive yearsAvg return: -20.2%Worst year: -64.8% (2022)

Technical Analysis Summary

Automated insights from historical price action and indicators

Technical Regime: POSITIVE
Trend Strength
100%
Positive
Volatility
42.5%
Very High
Momentum
+12.1%
30-day change
Support Level
24.03
Key floor
Key Insights
  • Price is currently trading above all key moving averages.
  • Elevated volatility indicates higher short-term price variability and risk.
  • Monitor key support and resistance levels as part of broader risk assessment.
openbook

Stock research for UK and US investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.